https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-fda-approval-of-tonmya-tm-x90rzddjnmp9.html
0
0
First New Fibromyalgia Drug in 15 Years: Tonix's Tonmya Approved for 10M+ US Patients After Strong Trial Results - Stock Titan
+ 63 more
8/15/25 at 7:44pm
Organization
Stocktitan.net
Author
Stock Titan
48 words
0
Comments
Tonmya, a non-opioid sublingual tablet, showed significant pain reduction in 1,000+ patient trials. Targets 10M+ US adults with fibromyalgia. Commercial launch set for Q4 2025.
You are the first to view
Create an account or login to join the discussion